Celiac panels

Clinical guidelines consistently recommend serological testing as the first step when celiac disease is suspected. IgA-based antibody testing, particularly tissue transglutaminase IgA, is widely recognized as the primary screening approach in individuals with normal IgA levels. For this reason, assessment of total IgA is an important part of the diagnostic workup.

In patients with IgA deficiency, which is more common among individuals with celiac disease than in the general population, IgG-based antibody tests are recommended to avoid false-negative results. The appropriate use of IgA and IgG markers supports a reliable and evidence-based diagnostic pathway.
Raising awareness about correct serological strategies is essential for improving early detection and reducing the risk of long-term complications associated with untreated celiac disease.

At AbBaltis, we support this diagnostic approach by supplying high-quality IgA and IgG materials used in celiac panels. Our focus is on enabling accurate and consistent testing that aligns with established clinical practice.

To explore our product catalogue, visit:
https://lnkd.in/eArWt5_X

For more information, please contact:
info@abbaltis.com